Comparison and commutability study between standardized liquid chromatography-mass spectrometry/mass spectrometry (LC-MS/MS) and chemiluminescent enzyme immunoassay for aldosterone measurement in blood.

Commutability Liquid chromatography-mass spectrometry/mass spectrometry Primary aldosteronism Standardization Traceability

Journal

Endocrine journal
ISSN: 1348-4540
Titre abrégé: Endocr J
Pays: Japan
ID NLM: 9313485

Informations de publication

Date de publication:
28 Jan 2022
Historique:
pubmed: 27 7 2021
medline: 5 4 2022
entrez: 26 7 2021
Statut: ppublish

Résumé

A commutability confirmation test for the blood aldosterone measurement was performed on liquid chromatography-mass spectrometry/mass spectrometry (LC-MS/MS) as a designated comparison method (DCM) and four chemiluminescent enzyme immunoassay (CLEIA) measurement procedures based on metrological traceability. A conventional radioimmunoassay (RIA) and two measurement procedures of CLEIA which obtains RIA equivalent values were also compared. The relationship between the DCM value and the CLEIA value with respect to 120 pg/mL of the RIA value, which is the screening criterion of primary aldosteronism (PA) was clarified. For the correlation test, 75 samples of patient serum and plasma were used. Regression analysis revealed that the standardized LC-MS/MS and four CLEIA measurement procedures were in good agreement. This is the effect of measurement specificity and calibration using by certified reference material (CRM). The median of the LC-MS/MS corresponding to 120 pg/mL of RIA was 48.5 pg/mL. In the mean of standardized four CLEIA values corresponding to the 48.5 pg/mL of LC-MS/MS value was 47.51 pg/mL and the standard deviation (SD) was 2.93 pg/mL. However, the correlation between the RIA value and the RIA equivalent of the two measurement procedures by CLEIA differed depending on the measurement procedure. This is due to the influence of RIA measurement performance. Standardized CLEIA measurements are suitable for routine measurement procedure. When converting the LC-MS/MS equivalent value by the standardized CLEIA to the conventional RIA value, it is necessary to use the conversion formula.

Identifiants

pubmed: 34305069
doi: 10.1507/endocrj.EJ21-0278
doi:

Substances chimiques

Aldosterone 4964P6T9RB

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

45-54

Auteurs

Tetsuo Nishikawa (T)

Endocrinology and Diabetes Center, Yokohama Rosai Hospital, Yokohama, Japan.

Fumitoshi Satoh (F)

Division of Clinical Hypertension, Endocrinology and Metabolism, Tohoku University Graduate School of Medicine, Division of Nehrology, Endocrinology and Vascular Medicine, Tohoku University Hospital, Sendai, Japan.

Yuichi Takashi (Y)

Department of Endocrinology and Diabetes Mellitus, Fukuoka University School of Medicine, Fukuoka, Japan.

Toshihiko Yanase (T)

Muta Hospital, Fukuoka, Japan.

Hiroshi Itoh (H)

Department of Endocrinology, Metabolism and Nephrology, Keio University School of Medicine, Tokyo, Japan.

Isao Kurihara (I)

Department of Endocrinology, Metabolism and Nephrology, Keio University School of Medicine, Tokyo, Japan.
Department of Medical Education, National Defense Medical College, Tokorozawa, Japan.

Hirotaka Shibata (H)

Department of Endocrinology, Metabolism, Rheumatology and Nephrology, Faculty of Medicine, Oita University, Yufu, Japan.

Yutaka Oki (Y)

Department of Metabolism and Endocrinology, Hamamatsu-Kita Hospital, Hamamatsu, Japan.

Mitsuhide Naruse (M)

Department of Endocrinology, Metabolism and Hypertension, National Hospital, Organization Kyoto Medical Center, Kyoto, Japan.

Hidehiko Sasamoto (H)

Aska Pharma Medical Co. Ltd., Fujisawa, Japan.

Katsuhiko Kuwa (K)

Japan Reference Measurement Institute, Tsukuba, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH